| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |